ScholarIQanswers from OpenAlex

Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center

PaperCitations, authors & open-access status

Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center have?

ScholarIQcitation count

Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center has 13 citations in the OpenAlex counts ScholarIQ stores.

When was Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center published?

ScholarIQyear

Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center has 2018 year in the ScholarIQ index.

What is the open-access status of Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center?

ScholarIQoa status

Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center has closed oa status in the ScholarIQ index.

What is the DOI of Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center?

ScholarIQdoi

The DOI for Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center is on the source record.

What is the PMID of Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center?

ScholarIQpmid

The PMID for Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center is on the source record.

What is the OpenAlex record for Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center?

ScholarIQopenalex

The OpenAlex for Metronomic therapy in metastatic castrate-resistant prostate cancer: Experience from a tertiary cancer care center is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial